(VIANEWS) – Simulations Plus (SLP), Knowles Corporation (KN), Zynex (ZYXI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Simulations Plus (SLP)
28.2% sales growth and 6.16% return on equity
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for noncompartmental analysis and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers KIWI, a cloud-based web application to organize, process, maintain, and communicate the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; RENAsym for investigating and predicting drug-induced or acute kidney injury; IPFsym, a software tool to treat or cure idiopathic pulmonary fibrosis; and the Monolix Suite, a solution for modeling and simulation. Further, the company provides population modeling and simulation contract research services; and clinical-pharmacology-based consulting services in support of regulatory submissions. It serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. The company was founded in 1996 and is headquartered in Lancaster, California.
Earnings Per Share
As for profitability, Simulations Plus has a trailing twelve months EPS of $0.52.
PE Ratio
Simulations Plus has a trailing twelve months price to earnings ratio of 92.6. Meaning, the purchaser of the share is investing $92.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.16%.
Moving Average
Simulations Plus’s worth is above its 50-day moving average of $47.44 and way higher than its 200-day moving average of $42.35.
Volume
Today’s last reported volume for Simulations Plus is 226160 which is 123.76% above its average volume of 101070.
2. Knowles Corporation (KN)
23% sales growth and 7.93% return on equity
Knowles Corporation designs, manufactures, and sells micro-acoustic, audio processing, and precision device solutions for the mobile consumer electronics, communications, medtech, defense, automotive, and industrial markets worldwide. It operates in two segments, Audio and Precision Devices (PD). The Audio segment designs and manufactures audio products, including microphones and balanced armature speakers, audio processors, and software and algorithms used in applications that serve the mobile, ear, and Internet of Things markets. The PD segment designs and delivers capacitor products and radio frequency solutions that are used in applications, such as power supplies and medical implants, satellite communication, and radar systems, as well as our telecommunications infrastructure customers. The company also provides single layer electronic components to the telecommunication, fiber optics, and defense markets. It sells its products directly to original equipment manufacturers and to their contract manufacturers and suppliers, as well as through distributors. The company was founded in 1946 and is headquartered in Itasca, Illinois.
Earnings Per Share
As for profitability, Knowles Corporation has a trailing twelve months EPS of $0.88.
PE Ratio
Knowles Corporation has a trailing twelve months price to earnings ratio of 19.32. Meaning, the purchaser of the share is investing $19.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.93%.
Volume
Today’s last reported volume for Knowles Corporation is 204989 which is 65.06% below its average volume of 586793.
Yearly Top and Bottom Value
Knowles Corporation’s stock is valued at $17.00 at 01:22 EST, below its 52-week high of $18.48 and way above its 52-week low of $12.78.
3. Zynex (ZYXI)
20.7% sales growth and 16.75% return on equity
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also supplies electrodes for the delivery of electrical current to the body and batteries for use in electrotherapy products; and distributes Comfortrac for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers blood volume monitor, a non-invasive medical device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Earnings Per Share
As for profitability, Zynex has a trailing twelve months EPS of $0.23.
PE Ratio
Zynex has a trailing twelve months price to earnings ratio of 40.52. Meaning, the purchaser of the share is investing $40.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.75%.
Volume
Today’s last reported volume for Zynex is 339658 which is 156.87% above its average volume of 132227.
Sales Growth
Zynex’s sales growth is 15.9% for the present quarter and 20.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 188.68M for the twelve trailing months.
Yearly Top and Bottom Value
Zynex’s stock is valued at $9.32 at 01:22 EST, way below its 52-week high of $13.77 and way higher than its 52-week low of $6.88.
4. LPL Financial Holdings (LPLA)
18.3% sales growth and 45.54% return on equity
LPL Financial Holdings Inc., together with its subsidiaries, provides an integrated platform of brokerage and investment advisory services to independent financial advisors and financial advisors at enterprises in the United States. Its brokerage offerings include variable and fixed annuities, mutual funds, equities, retirement and education savings plans, fixed income, and insurance, as well as alternative investments, such as non-traded real estate investment trusts and auction rate notes. The company also provides advisory platforms that provide access to mutual funds, exchange-traded funds, stocks, bonds, certain option strategies, unit investment trusts, and institutional money managers and no-load multi-manager variable annuities. In addition, it offers money market products; and retirement solutions for commission-and fee-based services that allow advisors to provide brokerage services, consultation, and advice to retirement plan sponsors. Further, the company provides other services comprising tools and services that enable advisors to maintain and grow their practices; trust, investment management oversight, and custodial services to trusts for estates and families, as well as insurance brokerage general agency services; and technology products, such as proposal generation, investment analytics, and portfolio modeling. The company was formerly known as LPL Investment Holdings Inc. and changed its name to LPL Financial Holdings Inc. in June 2012. LPL Financial Holdings Inc. was founded in 1989 and is based in San Diego, California.
Earnings Per Share
As for profitability, LPL Financial Holdings has a trailing twelve months EPS of $13.28.
PE Ratio
LPL Financial Holdings has a trailing twelve months price to earnings ratio of 21.06. Meaning, the purchaser of the share is investing $21.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.54%.
5. Erie Indemnity Company (ERIE)
11.9% sales growth and 30.15% return on equity
Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. The company provides sales, underwriting, policy issuance, and renewal services for the policyholders on behalf of the Erie Insurance Exchange. It also offers sales related services, including agent compensation, and sales and advertising support services; and underwriting services comprise underwriting and policy processing; and other services consist of customer services and administrative support services, as well as information technology services. Erie Indemnity Company was incorporated in 1925 and is based in Erie, Pennsylvania.
Earnings Per Share
As for profitability, Erie Indemnity Company has a trailing twelve months EPS of $9.26.
PE Ratio
Erie Indemnity Company has a trailing twelve months price to earnings ratio of 39.86. Meaning, the purchaser of the share is investing $39.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.15%.
Sales Growth
Erie Indemnity Company’s sales growth is 11.2% for the present quarter and 11.9% for the next.
6. Iron Mountain Incorporated (IRM)
9.2% sales growth and 47.37% return on equity
Iron Mountain Incorporated (NYSE: IRM), founded in 1951, is the global leader for storage and information management services. Trusted by more than 225,000 organizations around the world, and with a real estate network of more than 90 million square feet across more than 1,480 facilities in approximately 50 countries, Iron Mountain stores and protects billions of valued assets, including critical business information, highly sensitive data, and cultural and historical artifacts. Providing solutions that include secure records storage, information management, digital transformation, secure destruction, as well as data centers, cloud services and art storage and logistics, Iron Mountain helps customers lower cost and risk, comply with regulations, recover from disaster, and enable a more digital way of working.
Earnings Per Share
As for profitability, Iron Mountain Incorporated has a trailing twelve months EPS of $0.66.
PE Ratio
Iron Mountain Incorporated has a trailing twelve months price to earnings ratio of 139.06. Meaning, the purchaser of the share is investing $139.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 47.37%.
Volume
Today’s last reported volume for Iron Mountain Incorporated is 1351840 which is 20.21% below its average volume of 1694290.
7. Arrow Financial Corporation (AROW)
8.1% sales growth and 7.87% return on equity
Arrow Financial Corporation, a bank holding company, provides commercial and consumer banking, and financial products and services. The company's deposit products include demand deposits, interest-bearing checking accounts, savings deposits, time deposits, and other time deposits. Its lending activities comprise commercial loans, such as term loans, time notes, and lines of credit; and commercial real estate loans to finance real estate purchases, refinancing, expansions, and improvements to commercial properties, as well as commercial construction and land development loans to finance projects. The company's lending activities also include consumer installment loans to finance personal expenditures, personal lines of credit, overdraft protection, and automobile loans; and residential real estate loans, fixed home equity loans, and home equity lines of credit for consumers to finance home improvements, debt consolidation, education, and other uses. In addition, it maintains an indirect lending program; and sells residential real estate loan originations into the secondary market. Further, the company provides retirement planning, trust, and estate administration services for individuals; and pension, profit-sharing, and employee benefit plan administration services for corporations. Additionally, it offers insurance agency services comprising group health care policies and life insurance, and property and casualty insurance products; and investment advisory services to its proprietary mutual funds, as well as holds a real estate investment trust. The company operates in the northeastern region of New York State in Warren, Washington, Saratoga, Essex, Clinton, Rensselaer, Albany, and Schenectady counties, as well as surrounding areas. It owns 26 branch banking offices; and leases 12 branch banking offices, as well as two residential loan origination offices. Arrow Financial Corporation was founded in 1851 and is headquartered in Glens Falls, New York.
Earnings Per Share
As for profitability, Arrow Financial Corporation has a trailing twelve months EPS of $1.72.
PE Ratio
Arrow Financial Corporation has a trailing twelve months price to earnings ratio of 14.76. Meaning, the purchaser of the share is investing $14.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.87%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 10, 2024, the estimated forward annual dividend rate is 1.08 and the estimated forward annual dividend yield is 4.25%.
Volume
Today’s last reported volume for Arrow Financial Corporation is 59576 which is 38.08% above its average volume of 43146.
8. CBOE Holdings (CBOE)
7.7% sales growth and 21.09% return on equity
Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange worldwide. It operates through five segments: Options, North American Equities, Futures, Europe and Asia Pacific, and Global FX. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities. This segment also offers exchange-traded products (ETP) transaction and ETP listing services. The Futures segment trades in futures. The Europe and Asia Pacific segment offers pan-European listed equities and derivatives transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transactions services. The company has strategic relationships with S&P Dow Jones Indices, LLC; FTSE International Limited; Frank Russell Company; MSCI Inc.; and DJI Opco, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, CBOE Holdings has a trailing twelve months EPS of $7.47.
PE Ratio
CBOE Holdings has a trailing twelve months price to earnings ratio of 22.71. Meaning, the purchaser of the share is investing $22.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.09%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 18% and 2.9%, respectively.
